1. CMU Intellectual Repository

Browsing by Author Beatriz Grinsztejn

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 18 to 24 of 24 < previous 
Issue DateTitleAuthor(s)
16-Jul-2011Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trialJean Michel Molina; Pedro Cahn; Beatriz Grinsztejn; Adriano Lazzarin; Anthony Mills; Michael Saag; Khuanchai Supparatpinyo; Sharon Walmsley; Herta Crauwels; Laurence T. Rimsky; Simon Vanveggel; Katia Boven
1-Jan-2015Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: Implications for pre-exposure prophylaxis adherence monitoringMonica Gandhi; David V. Glidden; Albert Liu; Peter L. Anderson; Howard Horng; Patricia Defechereux; Juan V. Guanira; Beatriz Grinsztejn; Suwat Chariyalertsak; Linda Gail Bekker; Robert M. Grant
1-Sep-2019Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn; Michael D. Hughes; Justin Ritz; Robert Salata; Peter Mugyenyi; Evelyn Hogg; Linda Wieclaw; Robert Gross; Catherine Godfrey; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Faesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Anchalee Avihingsanon; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; B. Grinsztejn; P. N. Mugyenyi; A. Collier; R. Salata; C. Godfrey; E. Hogg; M. Hughes; J. Ritz; L. Wieclaw; T. Sise; J. W. Mellors; C. Wallis; C. V. Fletcher; M. Gandhi; R. Gross; R. T. Schooley; R. Walensky; M. van Schalkwyk; S. Faesen; R. Mngqibisa; J. Valencia; E. Montalban; N. Kumarasamy; C. Kanyama; S. W. Cardoso; B. R. Santos; B. Mansfield; H. Mugerwa; B. W. Ndege; R. Secours; W. Samaneka; D. Kadam; V. Mave; M. Makanga; S. N. Fontain; P. Sugandhavesa; A. Avihingsanon; L. Nakibuuka; H. Nassolo; P. Anthony; V. Kulkarni; M. Nsubuga; J. van Wyk; J. Rooney; Y. van Delft; R. Leavitt; R. Luk; A. Benns; L. Hovind; A. Shahkolahi
1-Jun-2022Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon; Michael D. Hughes; Robert Salata; Catherine Godfrey; Caitlyn McCarthy; Peter Mugyenyi; Evelyn Hogg; Robert Gross; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Badal-aesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije Van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Cornelius Munyanga; Maganizo Chagomerana; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; Beatriz Grinsztejn
1-Jan-2017Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 TrialSusan H. Eshleman; Sarah E. Hudelson; Andrew D. Redd; Ronald Swanstrom; San San Ou; Xinyi Cindy Zhang; Li Hua Ping; Estelle Piwowar-Manning; Stephen F. Porcella; Matthew F. Sievers; Craig A. Martens; Daniel Bruno; Elena Dukhovlinova; Marybeth McCauley; Theresa Gamble; Jessica M. Fogel; Devin Sabin; Thomas C. Quinn; Laurence Gunde; Madalitso Maliwichi; Nehemiah Nhando; Victor Akelo; Sikhulile Moyo; Ravindre Panchia; Nagalingeswaran Kumarasamy; Nuntisa Chotirosniramit; Marineide Gonçalves De Melo; Jose Pilotto; Beatriz Grinsztejn; Kenneth Mayer; Ying Q. Chen; James P. Hughes; Myron S. Cohen
15-Nov-2013Undisclosed antiretroviral drug use in a multinational clinical trial (HIV prevention trials network 052)Jessica M. Fogel; Lei Wang; Teresa L. Parsons; San San Ou; Estelle Piwowar-Manning; Ying Chen; Victor O. Mudhune; Mina C. Hosseinipour; Johnstone Kumwenda; James G. Hakim; Suwat Chariyalertsak; Ravindre Panchia; Ian Sanne; Nagalingeswaran Kumarasamy; Beatriz Grinsztejn; Joseph Makhema; Jose Pilotto; Breno R. Santos; Kenneth H. Mayer; Marybeth McCauley; Theresa Gamble; Namandjé N. Bumpus; Craig W. Hendrix; Myron S. Cohen; Susan H. Eshleman
4-May-2017Virologic outcomes in early antiretroviral treatment: HPTN 052Susan H. Eshleman; Ethan A. Wilson; Xinyi C. Zhang; San San Ou; Estelle Piwowar-Manning; Joseph J. Eron; Marybeth McCauley; Theresa Gamble; Joel E. Gallant; Mina C. Hosseinipour; Nagalingeswaran Kumarasamy; James G. Hakim; Ben Kalonga; Jose H. Pilotto; Beatriz Grinsztejn; Sheela V. Godbole; Nuntisa Chotirosniramit; Breno Riegel Santos; Emily Shava; Lisa A. Mills; Ravindre Panchia; Noluthando Mwelase; Kenneth H. Mayer; Ying Q. Chen; Myron S. Cohen; Jessica M. Fogel
Showing results 18 to 24 of 24 < previous